Effect of probiotics at different intervention time on glycemic control in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
consumers should review OpenLoop's telehealth consent at openloophealth.com/telehealth-consent and ask FeelGood support specific data privacy questions before enrollment FDA compounded GLP-1 adverse events: The FDA received 1,150+ adverse event reports related to compounded semaglutide/tirzepatide as of July 2025, including dosing errors with vial-based injectables
FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications
V., Russo, G., Giandalia, A., Viazzi, F., Pontremoli, R., & De Cosmo, S